An analysis of health-related quality of life in the phase III PROSELICA and FIRSTANA studies assessing cabazitaxel in patients with metastatic castration-resistant prostate cancer

BACKGROUND: Men with metastatic castration-resistant prostate cancer (mCRPC) are living longer, therefore optimizing health-related quality of life (HRQL), as well as survival outcomes, is important for optimal patient care. The aim of this study was to assess the HRQL in patients with mCRPC receivi...

Full description

Saved in:
Bibliographic Details
Published in:ESMO Open
Main Authors: Thiery-Vuillemin, A., Fizazi, K., Sartor, O., Oudard, S., Bury, D., Thangavelu, K., Ozatilgan, A., Poole, E.M., Eisenberger, M., de Bono, J.
Format: Artigo
Language:Inglês
Published: Elsevier 2021
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7980065/
https://ncbi.nlm.nih.gov/pubmed/33740734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.esmoop.2021.100089
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items